WallStreetZenWallStreetZen

NASDAQ: NVCR
Novocure Ltd Stock Ownership - Who owns Novocure?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novocure Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
W. Anthony VernonDirector2026-04-2821,500$11.39
$244.89kBuy
Mukund ParavasthuChief Operating Officer2026-03-0543,246$13.77
$595.67kSell
Ashley CordovaFormer Chief Executive Officer2026-03-0417,638$13.30
$234.59kSell
Christoph BrackmannChief Financial Officer2026-03-046,412$13.31
$85.31kSell
Frank X. LeonardChief Executive Officer2026-03-045,607$13.31
$74.60kSell
Nicolas LeupinFormer Chief Medical Officer2026-03-041,100$13.31
$14.64kSell
Mukund ParavasthuChief Operating Officer2026-03-045,377$13.31
$71.54kSell
Michal Nath PuriChief Human Resources Officer2026-03-041,100$13.31
$14.64kSell
URI WeinbergChf Medical and Innovation Ofr2026-03-046,412$13.31
$85.31kSell
William F. DoyleExecutive Chairman2026-03-0321,330$13.43
$286.44kSell

1 of 6

NVCR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NVCR insiders and whales buy or sell their stock.

NVCR Shareholders

What type of owners hold Novocure Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
William F. Doyle22.15%25,207,689$300.73MInsider
Fmr LLC14.76%16,796,979$200.39MInstitution
Gert L. Perlhagen12.32%14,018,365$167.24MInsider
Blackrock Inc11.90%13,541,448$161.55MInstitution
Vanguard Group Inc9.63%10,958,209$130.73MInstitution
Hansjoerg Wyss8.59%9,780,397$116.68MInsider
Soleus Capital Management LP7.50%8,530,665$101.77MInstitution
Volati Ltd6.34%7,216,789$86.10MInsider
Morgan Stanley4.46%5,069,895$60.48MInstitution
Pomona Capital VII LP2.41%2,741,925$32.71MInsider

1 of 3

NVCR vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NVCR59.25%40.75%Net SellingNet Selling
AORT79.97%20.03%Net SellingNet Selling
AHCO45.11%54.89%Net BuyingNet Buying
INSP66.30%33.70%Net SellingNet Selling
UFPT87.05%12.95%Net SellingNet Selling
View Top Medical Device Stocks

Novocure Stock Ownership FAQ

Who owns Novocure?

Novocure (NASDAQ: NVCR) is owned by 84.02% institutional shareholders, 57.78% Novocure insiders, and 0.00% retail investors. William F. Doyle is the largest individual Novocure shareholder, owning 25.21M shares representing 22.15% of the company. William F. Doyle's Novocure shares are currently valued at $383.41M.

If you're new to stock investing, here's how to buy Novocure stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.